
The alleged kingpin of a spurious drugs racket, Prashanth (named as R Prashanth Babu by the Times of India), who is in Special Investigation Team (SIT) custody, travelled to Turkey several times a year to procure original pharmaceutical labels, investigators have found. These labels were allegedly affixed to counterfeit medicines and passed off as genuine drugs. The Times of India reports that the labels were of a New York-based pharmaceutical company and were manufactured in Turkey. The Hindu states that Prashanth's Turkey visa was cancelled on multiple occasions.
Investigators suspect Prashanth also travelled to Azerbaijan, where he was holed up before his arrest, and used intermediaries to procure labels from Turkey after his visa was cancelled. The SIT has found that counterfeit medicines were sometimes mixed with genuine drugs before distribution. Officials are continuing to investigate the international network, including the role of intermediaries and destinations visited by the accused.
Both outlets report the core facts in a neutral, wire-style manner, but differ slightly in naming the kingpin and the pharmaceutical company. The Hindu uses the single name Prashanth and leaves the company unnamed, while the Times of India gives the full name R Prashanth Babu and specifies that the labels were for a New York-based firm manufactured in Turkey. Neither outlet adopts a critical or pro-government framing, both simply relay SIT findings. The uniform coverage means the story is still early-stage, with investigators questioning Prashanth further to map the full international network. The concrete next step is the ongoing SIT interrogation.
Coverage: 2 sources, 2 neutral
Sources (2): thehindu.com (neutral report), timesofindia.indiatimes.com (neutral report)
This brief was synthesised by AI from the 2 sources linked above, so one read covers every framing they carry. Methodology and corrections.